Navigation Links
Leprosy Genes Identified

Scientists pinpoint seven that increase susceptibility to disease

WEDNESDAY, Dec. 16 (HealthDay News) -- Seven genes associated with increased susceptibility to leprosy have been identified by scientists in Singapore and China.

The researchers, who analyzed more than 10,000 DNA samples from leprosy patients and healthy people in China, said their discovery highlights the important role that the innate immune response plays in the development of leprosy.

"Though leprosy is not common, the discoveries have significant ramifications for chronic infectious disorders and for host-pathogen interactions in other more prevalent mycobacterial diseases such as tuberculosis," Dr. Edison Liu, executive director of the Genome Institute of Singapore, said in a news release from the institute.

"The discovery of these genes is a major breakthrough for research in leprosy and infectious diseases in general, and will be significant in the early diagnosis and development of new treatments," study co-leader Jianjun Liu, Human Genetics Group Leader at the institute, said in the release.

The study appears online Dec. 16 in the New England Journal of Medicine.

The genes are: CCDC122, C13orf31, NOD2, TNFSF15, HLA-DR, RIPK2 and LRRK2.

Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. The disease, which mainly affects skin and peripheral nerves, is rare in developed countries, but remains a major public health problem in many developing countries. According to the World Health Organization, 254,525 new cases of leprosy were diagnosed in 2007.

In regions where leprosy is common, many people are exposed but only a few become infected and develop clinical signs of leprosy, which indicates that only certain people are susceptible to the disease.

More information

The U.S. National Library of Medicine has more about leprosy.

-- Robert Preidt

SOURCES: Agency for Science, Technology and Research, Singapore, news release, Dec. 16, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
2. Forgotten, but not gone: Leprosy still present in the US
3. Researchers identify new leprosy bacterium
4. Leprosy Lingers in the U.S.
5. Local Web Design Agency Launches Leprosy Charity Website for Women in Need
6. DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy
7. Pathway links inflammation, angiogenesis and breast cancer
8. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
9. New Database to Help Speed Search for Bipolar Disorder Genes
10. Is Perfect Pitch All in the Genes?
11. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: